Alpine Global Management, LLC Adma Biologics, Inc. Transaction History

Alpine Global Management, LLC

  • $331 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.43 - $2.2 $42,255 - $65,007
-29,549 Reduced 10.57%
250,000 $495,000
Q1 2022

May 13, 2022
BUY
$1.28 - $1.83 $37,822 - $54,074
29,549 Added 11.82%
279,549 $512,000
Q4 2021

Feb 14, 2022
BUY
$1.09 - $1.66 $260,896 - $397,329
239,355 Added 2248.52%
250,000 $353,000
Q2 2021

Aug 13, 2021
BUY
$1.51 - $2.07 $16,073 - $22,035
10,645 New
10,645 $17,000

Others Institutions Holding ADMA

# of Institutions
326
Shares Held
190M
Call Options Held
917K
Put Options Held
91.6K
View Full List

About ADMA BIOLOGICS, INC.

ADMA Quotes by TradingView
  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.31B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Alpine Global Management, LLC Portfolio

Follow Alpine Global Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Global Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email